免疫療法時代の非小細胞肺がんの脳転移に関する機会と課題
Ying Yu1, Yuxi Luo1, Fujuan Zeng1
1Department of Oncology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi 330006, China; Jiangxi Key Laboratory of Clinical Translational Cancer Research, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi 330006, China; Radiation Induced Heart Damage Institute, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi 330006, China.
Cancer treatment reviews
|August 28, 2025
まとめ
免疫チェックポイント阻害剤と併用した脳放射線治療は,非小細胞肺がんの脳転移に対して有望である. 患者の改善のためにこの組み合わせ治療を最適化するには,さらなる研究が必要です.
科学分野:
- 神経腫瘍学
- 放射線腫瘍学
- 医療腫瘍学
- 免疫療法
背景:
- 脳放射線療法 (BRT) は,非小細胞肺がんの脳転移 (NSCLC-BM) の伝統的な治療法である.
- 免疫チェックポイント阻害剤 (ICI) は有望ですが,血脳障壁の浸透性や腫瘍の微小環境などの要因により,NSCLC-BMにおける控えめな脳内有効性があります.
- 臨床前のデータによると,BRTは抗腫瘍免疫を改善することで,ICIの有効性を高める可能性がある.
研究 の 目的:
- NSCLC-BMに対するICIベースの全身療法における現在の進歩をレビューする.
- NSCLC-BMのBRTとICI (BRT-ICI) の組み合わせの機会と進展について議論する.
- BRT-ICI戦略を最適化するための課題と将来の方向性を特定する.
主な方法:
- BRT,ICI,およびNSCLC-BMにおけるそれらの組み合わせに関する現在の文献のレビュー.
- 臨床試験データと臨床前の証拠の分析
- 治療の配列,タイミング,放射線量,毒性,およびバイオマーカーの議論
主要な成果:
- BRTとICIの併用療法では,NSCLC- BMの臨床結果が望ましいことが示されています.
- 最近の第2相試験では,BRT-ICIと化学療法による高い応答率 (82. 5%) と生存指標の改善が報告されました.
- 最適なスケジュールとBRT-ICIの投与量分数は,現在も議論されている.
結論:
- BRTとICIの組み合わせはNSCLC-BMにとって有望な戦略です.
- 課題には神経学的毒性,放射性死滅,そして予測バイオマーカーの必要性があります.
- BRT-ICI治療プロトコルと患者の選択を最適化するために,さらなる研究が不可欠です.
関連する概念動画
01:27Tumor Immunotherapy
659
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
659
02:49Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
01:30Cancer Vaccines
509
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
509
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K